Pharmaceutical Recalls Losopan Antacid
August 17, 1999
Middletown, NY (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that RIJ Pharmaceutical Corporation is recalling
Losopan Antacid because of mislabeling. Some bottles bear an incorrect antacid back
label (Goldline Genaton).
Losopan Antacid (Magaldrate Oral Suspension Antacid
540 mg/5mL, in 12 fluid ounce bottles, OTC indicated for the relief of heartburn, sour
stomach and/or acid indigestion and upset stomach associated with these symptoms.NDC
Lot #81235 EXP 12/00.
RIJ Pharmaceutical Corporation, Middletown, New York.
Manufacturer, by letter and fax dated July 21, 1999. Firm-initiated recall ongoing.
5,208 bottles were distributed.